The nanomedicine exhibited outstanding anti‐tumor activity, superior cellular uptake, drug release properties, and modulation of the Hippo/YAP1/SOX9 pathway.[47] These findings reinforce the potential therapeutic value of this innovative nanomedicine. The gene discussed is YAP1; the disease is neoplasm.